174 related articles for article (PubMed ID: 3785155)
41. Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation.
Ciardiello F; McGeady ML; Kim N; Basolo F; Hynes N; Langton BC; Yokozaki H; Saeki T; Elliott JW; Masui H
Cell Growth Differ; 1990 Sep; 1(9):407-20. PubMed ID: 1981145
[TBL] [Abstract][Full Text] [Related]
42. Response of FR3T3 cells transformed by Ha-ras oncogene and epidermal growth factor gene to differentiation induction by N,N-dimethylformamide.
Levine AE; Chakrabarty S
Int J Cancer; 1992 Feb; 50(4):653-8. PubMed ID: 1537633
[TBL] [Abstract][Full Text] [Related]
43. Altered extracellular matrices influence cellular processes and nuclear matrix organizations of overlying human bladder urothelial cells.
Gordon JN; Shu WP; Schlussel RN; Droller MJ; Liu BC
Cancer Res; 1993 Oct; 53(20):4971-7. PubMed ID: 8402687
[TBL] [Abstract][Full Text] [Related]
44. Growth in culture and tumorigenicity after transfection with the ras oncogene of liver epithelial cells from carcinogen-treated rats.
Braun L; Goyette M; Yaswen P; Thompson NL; Fausto N
Cancer Res; 1987 Aug; 47(15):4116-24. PubMed ID: 2440558
[TBL] [Abstract][Full Text] [Related]
45. Prolonged inhibition by X-rays of DNA synthesis in cells obtained by transformation of primary rat embryo fibroblasts with oncogenes H-ras and v-myc.
Wang Y; Iliakis G
Cancer Res; 1992 Feb; 52(3):508-14. PubMed ID: 1732037
[TBL] [Abstract][Full Text] [Related]
46. Role of chromosome loss in ras/myc-induced Syrian hamster tumors.
Oshimura M; Koi M; Ozawa N; Sugawara O; Lamb PW; Barrett JC
Cancer Res; 1988 Mar; 48(6):1623-32. PubMed ID: 2449958
[TBL] [Abstract][Full Text] [Related]
47. Transfection of activated c-H-rasEJ/pSV2neo or pSV2neo genes into rat mammary cells: rapid stimulation of clonal diversification of spontaneous metastatic and cell-surface properties.
Nicolson GL; Gallick GE; Spohn WH; Lembo TM; Tainsky MA
Oncogene; 1992 Jun; 7(6):1127-35. PubMed ID: 1594244
[TBL] [Abstract][Full Text] [Related]
48. Proto-oncogene expression during retinoic acid-induced neural differentiation of embryonal carcinoma cells.
Nakamura KD; Hart RW
Mech Ageing Dev; 1989 Apr; 48(1):53-62. PubMed ID: 2725075
[TBL] [Abstract][Full Text] [Related]
49. Transfection by human oncogenes: concomitant induction of tumorigenicity and tumor-associated membrane alterations.
Collard JG; van Beek WP; Janssen JW; Schijven JF
Int J Cancer; 1985 Feb; 35(2):207-13. PubMed ID: 3855844
[TBL] [Abstract][Full Text] [Related]
50. Rat embryo cells immortalized with transfected oncogenes are transformed by gamma irradiation.
Endlich B; Salavati R; Sullivan T; Ling CC
Radiat Res; 1992 Dec; 132(3):301-11. PubMed ID: 1475353
[TBL] [Abstract][Full Text] [Related]
51. Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene.
Parada LF; Tabin CJ; Shih C; Weinberg RA
Nature; 1982 Jun; 297(5866):474-8. PubMed ID: 6283357
[TBL] [Abstract][Full Text] [Related]
52. Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors.
Spandidos DA
Anticancer Res; 1985; 5(5):485-98. PubMed ID: 3904595
[TBL] [Abstract][Full Text] [Related]
53. Metaplastic change in mesenchymal stem cells induced by activated ras oncogene.
Tzen CY; Filipak M; Scott RE
Am J Pathol; 1990 Nov; 137(5):1091-102. PubMed ID: 2240160
[TBL] [Abstract][Full Text] [Related]
54. A retinoic acid-induced clonal cell line derived from multipotential P19 embryonal carcinoma cells expresses smooth muscle characteristics.
Blank RS; Swartz EA; Thompson MM; Olson EN; Owens GK
Circ Res; 1995 May; 76(5):742-9. PubMed ID: 7728990
[TBL] [Abstract][Full Text] [Related]
55. Malignant properties of sublines selected from a human bladder cancer cell line that contains an activated c-Ha-ras oncogene.
Kovnat A; Buick RN; Choo B; De Harven E; Kopelyan I; Trent JM; Tannock IF
Cancer Res; 1988 Sep; 48(17):4993-5000. PubMed ID: 3409229
[TBL] [Abstract][Full Text] [Related]
56. Expression of the met/hepatocyte growth factor/scatter factor receptor and its ligand during differentiation of murine P19 embryonal carcinoma cells.
Yang XM; Park M
Dev Biol; 1993 Jun; 157(2):308-20. PubMed ID: 8388815
[TBL] [Abstract][Full Text] [Related]
57. v-myb transformation of Xeroderma pigmentosum human fibroblasts: overexpression of the c-Ha-ras oncogene in the transformed cells.
Michelin S; Varlet I; Martinerie C; Perbal B; Sarasin A; Suárez HG
Exp Cell Res; 1991 Oct; 196(2):314-22. PubMed ID: 1893942
[TBL] [Abstract][Full Text] [Related]
58. Enhanced lytic susceptibility of Ha-ras transformants after oncogene induction is specific to activated NK cells.
Johnson PW; Trimble WS; Hozumi N; Roder JC
J Immunol; 1987 Jun; 138(11):3996-4003. PubMed ID: 3495578
[TBL] [Abstract][Full Text] [Related]
59. Susceptibility to ras oncogene transformation is coregulated with signal transduction through growth factor receptors.
Chiao PJ; Kannan P; Yim SO; Krizman DB; Wu TA; Gallick GE; Tainsky MA
Oncogene; 1991 May; 6(5):713-20. PubMed ID: 1646984
[TBL] [Abstract][Full Text] [Related]
60. Regulated expression of a transfected human cardiac actin gene during differentiation of multipotential murine embryonal carcinoma cells.
Rudnicki MA; Ruben M; McBurney MW
Mol Cell Biol; 1988 Jan; 8(1):406-17. PubMed ID: 3275877
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
